Gastroprotective Capability of Exogenous Phosphatidylcholine in Experimentally Induced Chronic Gastric Ulcers in Rats

References

• Davenport HW. Gastric mucosal injury by fatty and acetyl-salicylic acids. Gastroenterology 1964; 46: 245–53
   PubMed Web of Science ®Google Scholar
• Silen W. New concept of the gastric mucosal barrier. Am J Surg 1977; 133: 8–12
   PubMed Web of Science ®Google Scholar
• Fromm D. Gastric mucosal barrier. Physiology of the gastrointestinal tract. Vol. 1. 2nd ed, L R Johnson. Raven Press, New York 1987; 733–48
   Google Scholar
• Wallace JL. Mucosal defense. New avenues for treatment of ulcer disease? Gastroenterol Clin N Am 1990; 19: 87–100
   PubMedGoogle Scholar
• Guth PH. Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective? Dig Dis Sci 1987; 32: 647–54
   PubMedGoogle Scholar
• Lauritsen K, Rask-Madsen J. Prostaglandin analogues. Clin Gastroenterol 1988; 2: 621–8
   Google Scholar
• Butler B D, Lichtenberger L M, Hills BA. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol 1983; 244: G645–51
   PubMed Web of Science ®Google Scholar
• Hills B A, Butler B D, Lichtenberger LM. Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 1983; 244: G561–8
   Google Scholar
• Schmitz M GJ, Renooij W. Phospholipids from rat, human, and canine gastric mucosa. Composition and metabolism of molecular classes of phosphatidylcholine. Gastroenterology 1990; 99: 1292–6
   PubMed Web of Science ®Google Scholar
• Lichtenberger L M, Graziani L A, Dial E J, Butler B D, Hills BA. Role of surface-active phospholipids in gastric cytoprotection. Science 1983; 219: 1327–9
   PubMed Web of Science ®Google Scholar
• Swarm R A, Ashley S W, Soybel D I, Ordway F S, Cheung LY. Protective effect of exogenous phospholipid on aspirin-induced gastric mucosal injury. Am J Surg 1987; 153: 48–53
   PubMed Web of Science ®Google Scholar
• Leyck S, Dereu N, Etschenberg E, et al. Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon® 100). Eur J Pharmacol 1985; 117: 35–42
   PubMed Web of Science ®Google Scholar
• Szelenyi I, Engler H. Cytoprotective role of gastric surfactant in the ethanol-produced gastric mucosal injury of the rat. Pharmacology 1986; 33: 199–205
   PubMedGoogle Scholar
• Kiviluoto T, Paimela H, Mustonen H, Kivilaakso E. Exogenous surface-active phospholipid protects Necturus gastric mucosa against luminal acid and barrier-breaking agents. Gastroenterology 1991; 100: 38–46
   PubMedGoogle Scholar
• McNeil P I, Ito S. Gastrointestinal cell plasma membrane wounding and resealing in vivo. Gastroenterology 1989; 96: 1238–48
   PubMed Web of Science ®Google Scholar
• Guth P H, Paulsen G, Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology 1984; 87: 1083–90
   PubMed Web of Science ®Google Scholar
• Djahanguiri B. The production of acute gastric ulceration by indomethacin in the rat. Scand J Gastroenterol 1969; 4: 265–7
   PubMed Web of Science ®Google Scholar
• Main I HM, Whittle B JR. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1975; 53: 217–24
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur J Pharmacol 1976; 40: 233–9
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Temporal relationship beween cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94–8
   PubMed Web of Science ®Google Scholar
• Satoh H, Inada I, Hirata T, Maki Y. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 1981; 81: 719–25
   PubMed Web of Science ®Google Scholar
• Brown C M, Rees WD. Gastroduodenal mucosal defence. Curr Opin Gastroenterol 1990; 6: 867–72
   Google Scholar
• Wallace JL. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 1991; 7: 870–5
   Google Scholar
• Hills BA. A physical identity for the gastric mucosal barrier. Med J Aust 1990; 153: 76–81
   PubMedGoogle Scholar
• Goddard P J, Kao Y-CJ, Lichtenberger LM. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology 1990; 98: 361–70
   PubMed Web of Science ®Google Scholar
• Kao Y-CJ, Goddard P J, Lichtenberger LM. Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain. Gastroenterology 1990; 98: 592–606
   PubMedGoogle Scholar
• Kao Y-CJ, Lichtenberger LM. Localization of phospholipid-rich zones in rat gastric mucosa: possible origin of a protective hydrophobic luminal lining. J Histochem Cytochem 1987; 35: 1285–98
   PubMed Web of Science ®Google Scholar
• Goggin P M, Northfleld T C, Spychal RT. Factors affecting gastric mucosal hydrophobicity in man. Scand J Gastroenterol 1991; 26: 65–73, Suppl 181
   PubMed Web of Science ®Google Scholar
• Spychal R T, Goggin P M, Marrero J M, et al. Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Gastroenterology 1990; 98: 1250–4
   PubMed Web of Science ®Google Scholar
• Lichtenberger L M, Richards J E, Hills BA. Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology 1985; 88: 308–14
   PubMed Web of Science ®Google Scholar
• Goddard P J, Hills B A, Lichtenberger LM. Does. aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol 1987; 252: G421–30
   Google Scholar
• Schoen R T, Vender RJ. Mechanisms of nonsteroidal antiinflammatory drug-induced gastric damage. Am J Med 1989; 86: 449–58
   PubMed Web of Science ®Google Scholar
• Shorrock C J, Rees W DW. Mechanisms of gastric damage by non-steroidal antiinflammatory drugs. Scand J Rheumatol 1989; 5–11, Suppl 78
   Google Scholar
• Ligumsky M, Golanska E M, Hansen D G, Kauffman GL, Jr. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology 1983; 84: 756–61
   PubMed Web of Science ®Google Scholar
• Rainsford KD. Mechanisms of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 1989; 24: 9–16, Suppl 163
   PubMed Web of Science ®Google Scholar
• Tarnawski A, Stachura J, Gergely H, Hollander D. Gastric microvascular endothelium: a major target for aspirin-induced injury and arachidonic acid protection. An ultrastructural analysis in the rat. Eur J Clin Invest 1990; 20: 432–40
   PubMedGoogle Scholar
• Silen W. Gastric mucosa defense and repair. Physiology of the gastrointestinal tract. Vol. 2. 2nd ed, L R Johnson. Raven Press, New York 1987; 1055–67
   Google Scholar
• Szabo S. Mechanisms of mucosal injury in the stomach and duodenum: time-sequence analysis of morphologic, functional, biochemical and histochemical studies. Scand J Gastroenterol 1987; 22: 21–8, Suppl 127
   Web of Science ®Google Scholar
• Hills BA. The biology of surfactant. Cambridge University Press, Cambridge 1988
   Google Scholar
• Tovey FI. Pathogenic mechanisms of acid-related disease: diet. Curr Opin Gastroenterol 1990; 6: 891–3
   Google Scholar
• Lacy E R, Ito S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 1982; 83: 619–25
   PubMed Web of Science ®Google Scholar
• Ohno T, Ohtsuki H, Okabe S. Effects of 16,16-dimethyl prostaglandin E2 on ethanol-induced and aspirin-induced gastric damage in the rat. Scanning electron microscope study. Gastroenterology 1985; 88: 353–61
   PubMed Web of Science ®Google Scholar
• Lacy ER. Prostaglandins and histological changes in the gastric mucosa. Dig Dis Sci 1985; 30: 83S–94S, Suppl
   Google Scholar
• Liss R H, Letourneau M A, Schepis BS. Evaluation of cytoprotection against ethanol-induced injury in gastric mucosa pre-treated with misoprostol, cimetidine, or placebo. Dig Dis Sci 1986; 31: 108S–14S, Suppl
   Google Scholar